Journal of Medicinal Chemistry p. 1086 - 1094 (1991)
Update date:2022-07-31
Topics:
Showell, Graham A.
Gibbons, Tracey L.
Kneen, Clare O.
MacLeod, Angus M.
Merchant, Kevin
et al.
Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying high efficacy at cortical sites.The current paper describes the synthesis and biochemical assesment of semirigid muscarinic ligands which were used to map the requirements of the cortical muscarinic receptor and to study the degree of conformational flexibility required to cause receptor activation.Analogues 6 and 9 provide high-efficacy muscarinic agonist at cortical sites; however, C-alkylation on the tetrahydropyridine ring resulted in more rigid analogues and showed lower predicted efficacy.Molecular mechanics calculations indicated a preference for the E rotameric form.This conformation was also observed in the X-ray crystal structure of ethenyloxadiazole 12.The new compounds were tested in biochemical assay designed to measure receptor affinity and to predict cortical efficacy.
View MoreHUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
jiangsu hualin chemical co.,ltd.
Contact:86-25-87787402
Address:jaingsu,china
YanCheng LongShen Chemical Co.,Ltd.
Contact:+86-515-86668866
Address:No.13,Weiyi Road,Funing Aoyang Industrial Park
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Doi:10.1021/ja00967a011
(1966)Doi:10.1016/S0040-4020(01)01061-4
(2001)Doi:10.1021/ja01196a036
(1947)Doi:10.1021/ja01600a036
(1956)Doi:10.1021/ol502515b
(2014)Doi:10.1021/jm00092a020
(1992)